U.S. and France play catch-up on Karabakh after Russia deploys troops
Yelpin (Reuters) – France and the United States are expected to send diplomats to Moscow soon to discuss the Nagorno-Karabakh
Read More
Factual Version of a Story
Latest
Saudi embassy in The Hague sprayed with gunfire, police arrest suspect
The Hague (Reuters) – Dutch police on Thursday said they had arrested a suspect after the embassy of Saudi Arabia
Read More
‘When saliva runs out, one has to have gunpowder,’ Brazil’s Bolsonaro says in swipe at Biden
Brasilia (Reuters) – Brazilian President Jair Bolsonaro, who portrays himself as a close friend of U.S. President Donald Trump, took
Read More
Analysis: Russia and Turkey keep powder dry in Nagorno-Karabakh conflict
Baku (Reuters) – Sensitive to the threat of wider confrontation, Russia and Turkey are for now limiting involvement in the
Read More
Bahrain’s Sheikh Khalifa, world’s longest serving prime minister, dies
Manama (Reuters) – Bahrain’s Sheikh Khalifa bin Salman al Khalifa, the world’s longest serving prime minister and a staunch ally
Read More
Iran frees 157 detained during protests as more U.S. sanctions loom
Dubai (Reuters) – Iran has freed 157 people arrested during anti-government demonstrations, the country’s judiciary said on Tuesday, as the
Read More
U.S. imposes Iran-related sanctions on individuals, companies
Washington (Reuters) – The United States on Tuesday imposed Iran-related sanctions on six companies and four people, accusing the network
Read More
U.S. approves $23.37 billion sale of advanced defense equipment to UAE, Pompeo says
Washington (Reuters) – The U.S. has approved the sale of a $23.37 billion package of advanced defense equipment to the
Read More
Republicans back Trump’s right to challenge Biden victory
Wilmington, Del. (Reuters) – President Donald Trump will push ahead on Tuesday with longshot legal challenges to his election loss,
Read More
We may soon have a COVID-19 vaccine. But will enough people take it?
London (Reuters) – With COVID-19 vaccine trial results looking positive, governments and pharmaceutical firms face their next daunting challenge: convincing
Read More